Acepodia
Dr. Yu-Shiang Chang is a clinician at Tai-Cheng Cell Therapy Center, National Taiwan University Cancer Center. Besides practicing medicine in hematology and oncology, Dr. Chang leads research efforts focusing on the development of the next generation of cellular immunotherapies. He received his M.D. from China Medical University and Ph.D. from National Sun Yat-sen University. Dr. Chang was the postdoctoral fellow at the National University Hospital in Singapore, and St. Jude Children's Research Hospital in Tennessee.
This person is not in the org chart
This person is not in any offices
Acepodia
2 followers
Acepodia is using its proprietary bioconjugation technology to develop the next wave of off-the-shelf cell therapies for cancer.